Description
Toujeo Max, a long-acting insulin formulated as a sterile solution for subcutaneous injection, boasting a concentration of 300 units/mL. Crafted through innovative recombinant DNA technology, Insulin Glargine originates from a non-pathogenic Escherichia coli laboratory strain.
The Tujeo injection presents itself as a sterile, colorless, and aqueous solution, designed for subcutaneous administration. This innovative solution is also conveniently available in the user-friendly Toujeo SoloStar prefilled pen.
Reviews
There are no reviews yet.